Table 3.
Performance of signatures in predicting relapse in Stockholm validation cohort.
| Signature | Gene # | Log rank p-value |
|---|---|---|
| 100-gene set | 100 | 0.0330 |
| iCluster1 | 32 | 0.0295 |
| iCluster2 | 44 | 0.0185 |
| iCluster3 | 36 | 0.0263 |
| iCluster4 | 50 | 0.0001 |
| iCluster5 | 45 | 0.1560 |
| Sharma et al. (2013)29 | 16 | 0.1744 |
| Ramos-Montoya et al. (2014)10 | 222 | 0.1892 |
| Cuzick et al. (2011)36 | 31 | 0.2631 |
| Irshad et al. (2013)8 | 19 | 0.8525 |
| Lalonde et al. (2014)13 | 100 | 0.4953 |
| OncoType Dx | 17 | 0.7323 |